Evotec Secures $2.9 Mln Grant To Advance Early Drug Safety Testing Using Human Stem Cell Technology
Nov 16 (Reuters) - EVOTEC SE EVTG.DE:
SECURES $2.9 MILLION GRANT TO ADVANCE EARLY DRUG SAFETY TESTING USING HUMAN STEM CELL TECHNOLOGY
RECEIVES THREE-YEAR GRANT FROM GATES FOUNDATION TO EXTEND 2023 PROJECT
Further company coverage: EVTG.DE